Differential effects of two chronic diazepam treatment regimes on withdrawal anxiety and AMPA receptor characteristics
- PMID: 15970947
- DOI: 10.1038/sj.npp.1300800
Differential effects of two chronic diazepam treatment regimes on withdrawal anxiety and AMPA receptor characteristics
Abstract
Withdrawal from chronic benzodiazepines is associated with increased anxiety and seizure susceptibility. Neuroadaptive changes in neural activity occur in limbo-cortical structures although changes at the level of the GABA(A) receptor do not provide an adequate explanation for these functional changes. We have employed two diazepam treatment regimes known to produce differing effects on withdrawal aversion in the rat and examined whether withdrawal-induced anxiety was accompanied by changes in AMPA receptor characteristics. Rats were given 28 days treatment with diazepam by the intraperitoneal (i.p.) route (5 mg/kg) and the subcutaneous (s.c.) route (15 mg/kg). Withdrawal anxiety in the elevated plus maze was evident in the group withdrawn from chronic s.c. diazepam (relatively more stable plasma levels) but not from the chronic i.p. group (fluctuating daily plasma levels). In the brains of these rats, withdrawal anxiety was accompanied by increased [3H]Ro48 8587 binding in the hippocampus and thalamus, and decreased GluR1 and GluR2 subunit mRNA expression in the amygdala (GluR1 and GluR2) and cortex (GluR1). The pattern of changes was different in the chronic i.p. group where in contrast to the chronic s.c. group, there was reduced [3H]Ro48 8587 binding in the hippocampus and no alterations in GluR1 and GluR2 subunit expression in the amygdala. While both groups showed reduced GluR1 mRNA subunit expression in the cortex overall, only the agranular insular cortex exhibited marked reductions following chronic i.p. diazepam. Striatal GluR2 mRNA expression was increased in the i.p. group but not the s.c. group. Taken together, these data are consistent with differential neuroadaptive processes in AMPA receptor plasticity being important in withdrawal from chronic benzodiazepines. Moreover, these processes may differ both at a regional and receptor function level according to the behavioral manifestations of withdrawal.
Similar articles
-
alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate receptor autoradiography in mouse brain after single and repeated withdrawal from diazepam.Eur J Neurosci. 2005 Feb;21(4):1045-56. doi: 10.1111/j.1460-9568.2005.03902.x. Eur J Neurosci. 2005. PMID: 15787709
-
Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes.Behav Pharmacol. 2002 Sep;13(5-6):417-25. doi: 10.1097/00008877-200209000-00015. Behav Pharmacol. 2002. PMID: 12394418
-
Glutamate receptor antagonism in inferior colliculus attenuates elevated startle response of high anxiety diazepam-withdrawn rats.Neuroscience. 2009 Jul 7;161(3):707-17. doi: 10.1016/j.neuroscience.2009.03.073. Epub 2009 Apr 5. Neuroscience. 2009. PMID: 19348870
-
Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence.Psychopharmacology (Berl). 1993;112(1):21-5. doi: 10.1007/BF02247359. Psychopharmacology (Berl). 1993. PMID: 7871006 Review.
-
Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.CNS Drugs. 2017 Feb;31(2):87-95. doi: 10.1007/s40263-016-0403-y. CNS Drugs. 2017. PMID: 28101764 Review.
Cited by
-
Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A, and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal CA1 synapses during benzodiazepine withdrawal.J Comp Neurol. 2010 Nov 1;518(21):4311-28. doi: 10.1002/cne.22458. J Comp Neurol. 2010. PMID: 20853509 Free PMC article.
-
Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice.Front Aging Neurosci. 2021 Nov 26;13:777404. doi: 10.3389/fnagi.2021.777404. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34899279 Free PMC article.
-
Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.Pharmacol Biochem Behav. 2008 Jul;90(1):74-89. doi: 10.1016/j.pbb.2008.01.001. Epub 2008 Jan 12. Pharmacol Biochem Behav. 2008. PMID: 18295321 Free PMC article. Review.
-
Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?Adv Pharmacol Sci. 2012;2012:416864. doi: 10.1155/2012/416864. Epub 2012 Mar 29. Adv Pharmacol Sci. 2012. PMID: 22536226 Free PMC article.
-
The rapid hydrolysis of chlordiazepoxide to demoxepam may affect the outcome of chronic osmotic minipump studies.Psychopharmacology (Berl). 2010 Mar;208(4):555-62. doi: 10.1007/s00213-009-1752-8. Psychopharmacology (Berl). 2010. PMID: 20066402 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical